Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,522 | 38,590 | 26,435 | 17,184 | 29,648 |
| Marketable Securities | 15,908 | 37,249 | 60,936 | 77,338 | 67,968 |
| TOTAL | $71,694 | $82,345 | $91,687 | $100,338 | $101,447 |
| Non-Current Assets | |||||
| PPE Net | 1,121 | 937 | 1,023 | 1,083 | 1,086 |
| Investments And Advances | 0 | 0 | 0 | 1,469 | 10,171 |
| Intangibles | 23 | 25 | 25 | 27 | 30 |
| Other Non-Current Assets | 1,988 | 874 | 1,028 | 1,202 | 1,404 |
| TOTAL | $3,132 | $1,836 | $2,076 | $3,781 | $12,691 |
| Total Assets | $74,826 | $84,181 | $93,763 | $104,119 | $114,138 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 0 | 540 |
| Accounts payable and accrued liabilities | 200 | 947 | 792 | 601 | 406 |
| Accrued Expenses | 3,400 | 5,403 | 4,926 | 3,861 | 2,489 |
| Other current liabilities | 797 | 1,149 | 764 | 801 | 2,247 |
| TOTAL | $4,397 | $7,499 | $6,482 | $5,263 | $5,682 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,401 | 274 | 476 | 675 | 868 |
| TOTAL | $1,401 | $274 | $476 | $675 | $868 |
| Total Liabilities | $5,798 | $7,773 | $6,958 | $5,938 | $6,550 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,234 | 66,243 | 65,500 | 65,466 | 65,466 |
| Common Shares | 66 | 66 | 66 | 65 | 65 |
| Retained earnings | -569,205 | -559,571 | -546,780 | -532,718 | -521,682 |
| Other shareholders' equity | 15 | 55 | 125 | -82 | -40 |
| TOTAL | $69,028 | $76,408 | $86,805 | $98,181 | $107,588 |
| Total Liabilities And Equity | $74,826 | $84,181 | $93,763 | $104,119 | $114,138 |